Literature DB >> 383104

[Piracetam and vigilance. A study of EEG changes and clinical effects in gerontopsychiatric patients (author's transl)].

D Bente, G Glatthaar, G Ulrich, M Lewinsky.   

Abstract

The electroencephalographic and clinical effects of piracetam were studied in a group of 11 hospitalized gerontopsychiatric patients treated with a daily dosage of 4.8 g for 8--13 months. The EEG was evaluated by power spectral analysis, followed by a principal component analysis of frequency parameters. The statistical analysis of the resulting factor scores shows that piracetam induces significant EEG changes: decrease of slow frequencies, augmentation and acceleration of alpha-activity and increase of beta-activity. These EEG changes, indicating an increase in vigilance, correspond clinically to an improvement of communicative behavior and cognitive functioning.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 383104

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  7 in total

1.  Cerebral-activating (EEG) properties of two inverse agonists and of an antagonist at the benzodiazepine receptor in the rat.

Authors:  V Santucci; M Fournier; P Worms; P Keane; K Bizière
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

Review 2.  'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.

Authors:  A Spagnoli; G Tognoni
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

3.  Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo.

Authors:  M Koskiniemi; B Van Vleymen; L Hakamies; S Lamusuo; J Taalas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

4.  Arousal deficit shown in aged rat's quantitative EEG and ameliorative action of pramiracetam compared to piracetam.

Authors:  B P Poschel; P M Ho; F W Ninteman
Journal:  Experientia       Date:  1985-11-15

5.  Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment.

Authors:  G Chouinard; L Annable; A Ross-Chouinard; M Olivier; F Fontaine
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 6.  Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders.

Authors:  M W Vernon; E M Sorkin
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

7.  Effect of piracetam on EEG spectra of boys with learning disorders.

Authors:  J Volavka; J Simeon; S Simeon; D Cho; D Reker
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.